News Chart Seikagaku Corporation

Equities

4548

JP3414000004

Delayed Japan Exchange Other stock markets 09:00:06 2024-05-15 pm EDT			5-day change	1st Jan Change
773 ^JPY	-0.39%		+3.78%	+0.92%

Apr. 08	Ferring Pharmaceuticals Inc. Presents Pivotal Phase 3 Efficacy and Safety Data for Investigational Treatment, SI-6603, in Lumbar Disc Herniation at ASIPP 2024	CI
2023	Seikagaku Corporation Reports Earnings Results for the Full Year Ended March 31, 2023	CI

6a5e5aea518c570d154.UseS-O10YxCvUjDqSY-EsZEC5JebQDNXm9WPCQnya0U.A5L0zKdBJ1b-K1iPE97i3sVHrtbPI0MD1YzkOGXEJioUk_Sy3B4bJoJ_Uw~ea5d12a381d2fe3d85b82d3311a35d81